XML 36 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1

Business Segments (Tables)

3 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Schedule of information regarding reportable segments

			Three Months
For the Periods Ended September 30			2017						2016
Net sales
MFAs and other				$	79,603					$	83,419
Nutritional Specialties					30,777						26,304
Vaccines					18,461						14,778
Animal Health					128,841						124,501
Mineral Nutrition					52,073						51,592
Performance Products					12,498						11,894
Total segments				$	193,412					$	187,987
Depreciation and amortization
Animal Health				$	5,254					$	4,898
Mineral Nutrition					585						542
Performance Products					246						218
Total segments				$	6,085					$	5,658
Adjusted EBITDA
Animal Health				$	33,742					$	32,619
Mineral Nutrition					3,716						3,988
Performance Products					248						742
Total segments				$	37,706					$	37,349
Reconciliation of income before income taxes to Adjusted EBITDA
Income before income taxes				$	18,944					$	17,572
Interest expense, net					3,118						3,907
Depreciation and amortization – Total segments					6,085						5,658
Depreciation and amortization – Corporate					559						660
Corporate costs					7,589						7,524
Acquisition-related cost of goods sold					249						—
Acquisition-related accrued compensation					437						420
Acquisition-related transaction costs					400						1,274
Foreign currency (gains) losses, net					325						334
Adjusted EBITDA – Total segments				$	37,706					$	37,349

As of			September 30, 2017						June 30, 2017
Identifiable assets
Animal Health				$	479,075					$	442,521
Mineral Nutrition					60,371						55,184
Performance Products					22,331						23,681
Total segments					561,777						521,386
Corporate					109,334						102,011
Total				$	671,111					$	623,397

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration